{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Schreck LD"],"funding":["Lungenliga Schweiz","Swiss National Science Foundation","PCD Foundation, United States","PCD Australia","Verein Kartagener Syndrom und Primöre Ciliöre Dyskinesie, Germany","PCD Support UK"],"pagination":["e0001522"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10495017"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["3(9)"],"pubmed_abstract":["Diagnostic tests are important in primary ciliary dyskinesia (PCD), a rare disease, to confirm the diagnosis and characterize the disease. We compared diagnostic tests for PCD between countries worldwide, assessed whether people with PCD recall their tests, and identified factors associated with the use of tests. We used cross-sectional data from COVID-PCD-an international participatory cohort study collecting information directly from people with PCD. The baseline questionnaire inquired about tests used for PCD diagnosis. Using logistic regression, we investigated factors associated with measurement of nasal nitric oxide (nNO), biopsy for electron or video microscopy, and genetic testing. We included data from 747 participants (60% females) from 49 countries worldwide with median age 27 ("],"journal":["PLOS global public health"],"pubmed_title":["Diagnostic testing in people with primary ciliary dyskinesia: An international participatory study."],"pmcid":["PMC10495017"],"funding_grant_id":["2021-08_Pedersen","185923","320030B_192804/1","192804"],"pubmed_authors":["Lucas JS","Schreck LD","Muller L","Goutaki M","Cizeau I","Pedersen ESL","Kruljac C","Kuehni CE","COVID-PCD patient advisory group"],"additional_accession":[]},"is_claimable":false,"name":"Diagnostic testing in people with primary ciliary dyskinesia: An international participatory study.","description":"Diagnostic tests are important in primary ciliary dyskinesia (PCD), a rare disease, to confirm the diagnosis and characterize the disease. We compared diagnostic tests for PCD between countries worldwide, assessed whether people with PCD recall their tests, and identified factors associated with the use of tests. We used cross-sectional data from COVID-PCD-an international participatory cohort study collecting information directly from people with PCD. The baseline questionnaire inquired about tests used for PCD diagnosis. Using logistic regression, we investigated factors associated with measurement of nasal nitric oxide (nNO), biopsy for electron or video microscopy, and genetic testing. We included data from 747 participants (60% females) from 49 countries worldwide with median age 27 (","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023","modification":"2026-05-28T12:15:48.242Z","creation":"2025-04-07T10:16:54.93Z"},"accession":"S-EPMC10495017","cross_references":{"pubmed":["37695754"],"doi":["10.1371/journal.pgph.0001522"]}}